Impact of Integrated Health System Specialty Pharmacy Services on Inflammatory Bowel Disease Outcomes
This poster presents an assessment of how health system specialty pharmacy (HSSP) services can improve clinical outcomes for IBD patients.
This poster presents an assessment of how health system specialty pharmacy (HSSP) services can improve clinical outcomes for IBD patients.
This poster evaluates the critical role of health system specialty pharmacies in addressing social determinants of health (SDOH) barriers through tailored interventions.
This poster describes the impact of implementing ambulatory clinical pharmacist (ACP)-led medication management services specializing in diabetes care within an integrated HSSP.
This poster highlights how the implementation of clinical outcome dashboards helps improve quality of care, patient satisfaction, and overall organizational performance and capabilities in health system specialty pharmacies.
RA is an autoimmune and inflammatory disease where the immune system attacks healthy cells, causing inflammation and painful swelling in the affected parts of the body.
MS is a chronic, autoimmune disease of the central nervous system, affecting the communication between the brain and other parts of the body